Home > News > Triton's nanotechnology designed to take on tumors
May 1st, 2004
Triton's nanotechnology designed to take on tumors
Samuel Straface is betting that nanotechnology originally designed to repair military vehicles can be successfully used for something far different: to kill cancer tumors. Straface is president and CEO of Triton BioSystems Inc. in Chelmsford, a 3-year-old biotechnology/medical device company hybrid. And he believes the company's system will essentially fry a tumor without significant side effects, ultimately helping to treat patients in lieu of toxic chemotherapy or radiation.
Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014
Journal Nanotechnology Progress International (JONPI), 2014, Volume 5, Issue 1, pp 1-24 October 22nd, 2014
TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014
‘Designer’ nanodevice could improve treatment options for cancer sufferers October 22nd, 2014